/PSIQ

PSIQ Stock - Profile Solutions, Inc.

Q: What is the analyst price target for PSIQ?

Analyst price target information is not currently available for PSIQ.

Q: What is PSIQ's market cap?

Market capitalization information is not currently available for PSIQ.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PSIQ

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2015

FY2016

FY2017

FY2018

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-10.33

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2018	FY2017	FY2016	FY2015
Revenue	$876,448	$208,236	$247,436	N/A
Gross Profit	$484,433	$113,463	$44,656	$-958
Gross Margin	55.3%	54.5%	18.0%	N/A
Operating Income	$-511,530	$-42,500	$-41,190	$-126,230
Net Income	$-511,565	$-42,495	$-41,192	$-126,226
Net Margin	-58.4%	-20.4%	-16.6%	N/A
EPS	$-0.00	$-0.00	$-0.00	$-0.00

Company Overview

Profile Solutions, Inc., through its subsidiary, Elite Products International, Inc., manufactures and distributes cannabinoid hemp extracts in the form of edibles, creams, oils, and salves. It offers edibles, such as candies, gummies, cookies, crystal pops, honey and multi-vitamins, oils, tinctures, vapes, creams, and salves, as well as a line of creams and salves for house pets. The company is headquartered in Sunrise, Florida.

Visit Website

Earnings History & Surprises

PSIQ

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$N/A

EPS Surprise History

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2018	Nov 13, 2018	—	—	—	—

Frequently Asked Questions about PSIQ

What is PSIQ's current stock price?

Profile Solutions, Inc. (PSIQ) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for PSIQ?

No analyst price targets are currently available for this stock.

What sector is Profile Solutions, Inc. in?

Profile Solutions, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is PSIQ's market cap?

Profile Solutions, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does PSIQ pay dividends?

No, Profile Solutions, Inc. does not currently pay a dividend to shareholders.